Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

PULMBullishM&Anews

High materiality8/10

Pulmatrix merges with Eos SENOLYTIX; combined entity to trade as MTXL

Sep 22, 2026, 8:51 AM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Direct exposure to a transformative merger with a near-term vote and closing window; completion would reset valuation and liquidity via MTXL listing, potentially triggering upside, barring deal risks or financing dilution.

AI summary

What happened, with direct paths to the underlying reporting

Pulmatrix (PULM) announced a merger with private Eos SENOLYTIX, with the combined company to trade under MTXL. The deal hinges on a stockholder vote set for Oct 16, 2026 and is targeted to close in Q4 2026, supported by financing for the pipeline. The transaction links Pulmatrix’s inhaled therapies with Eos’s aging-biology program, potentially reshaping the near-term value and completing a transition to a new platform.

Pulmatrix to merge with Eos SENOLYTIX; post-close ticker MTXL.
Stockholders vote Oct 16, 2026; closing expected in Q4 2026.
Financing to support the combined pipeline and key milestones.
Eos to present at World Congress on Targeting Mitochondria Oct 21-23, 2026.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.